Skip to main content
. Author manuscript; available in PMC: 2021 Feb 16.
Published in final edited form as: J Nucl Med. 2017 Oct 6;59(4):625–631. doi: 10.2967/jnumed.117.199554

Table 3. Absorbed Organ and Whole-Body Doses of 68Ga-THP-PSMA.

Organ Absorbed dose in patient: Mean absorbed dose Median absorbed dose
1 2 3 4 5 6 7 8
   Adrenal glands 7.00E–03 6.01E–03 7.36E–03 5.02E–03 4.85E–03 5.88E–03 5.57E–03 5.33E–03 5.88E–03 5.72E–03
   Brain 1.14E–03 1.31E–03 2.15E–03 1.15E–03 1.20E–03 1.29E–03 9.35E–04 1.47E–03 1.33E–03 1.24E–03
   Gallbladder 9.89E–03 7.54E–03 1.11E–02 7.24E–03 9.00E–03 8.42E–03 1.33E–02 7.03E–03 9.20E–03 8.71E–03
   Lower large intestine 1.92E–02 8.42E–03 1.32E–02 6.63E–03 1.00E–02 9.39E–03 8.78E–03 1.01E–02 1.07E–02 9.71E–03
   Small intestine 1.71E–02 1.44E–02 1.52E–02 2.25E–02 1.53E–02 1.53E–02 1.25E–02 1.36E–02 1.57E–02 1.53E–02
   Stomach 9.89E–03 7.85E–03 1.17E–02 7.49E–03 7.84E–03 8.03E–03 7.70E–03 6.86E–03 8.42E–03 7.84E–03
   Upper large intestine 8.04E–03 7.46E–03 9.96E–03 6.34E–03 7.36E–03 7.24E–03 6.48E–03 7.16E–03 7.50E–03 7.30E–03
   Heart 1.04E–02 1.55E–02 2.80E–02 1.42E–02 1.55E–02 1.62E–02 1.50E–02 1.18E–02 1.58E–02 1.53E–02
   Kidneys 7.26E–02 6.05E–02 9.07E–02 8.89E–02 9.13E–02 9.91E–02 5.87E–02 7.60E–02 7.97E–02 8.24E–02
   Liver 1.83E–02 1.08E–02 1.79E–02 1.10E–02 1.52E–02 1.11E–02 1.05E–02 1.02E–02 1.31E–02 1.10E–02
   Lungs 1.69E–02 1.18E–02 1.85E–02 1.53E–02 1.53E–02 1.56E–02 1.33E–02 1.09E–02 1.47E–02 1.53E–02
   Muscle 5.15E–03 4.23E–03 5.69E–03 3.44E–03 4.50E–03 4.43E–03 4.25E–03 4.04E–03 4.47E–03 4.34E–03
   Pancreas 9.41E–03 7.19E–03 1.46E–02 9.92E–03 1.30E–02 8.82E–03 8.26E–03 8.60E–03 9.98E–03 9.11E–03
   Red marrow 9.86E–03 8.20E–03 1.05E–02 6.87E–03 7.58E–03 7.89E–03 7.57E–03 7.69E–03 8.27E–03 7.79E–03
   Osteogenic cells 1.24E–02 1.07E–02 1.35E–02 8.52E–03 8.61E–03 1.00E–02 1.03E–02 9.52E–03 1.04E–02 1.02E–02
   Skin 4.56E–03 4.13E–03 4.55E–03 2.93E–03 2.79E–03 3.65E–03 3.70E–03 3.56E–03 3.73E–03 3.68E–03
   Spleen 1.56E–02 1.14E–02 1.63E–02 1.47E–02 1.38E–02 1.32E–02 1.05E–02 9.65E–03 1.31E–02 1.35E–02
   Testes 1.12E–02 9.65E–03 1.08E–02 1.05E–02 1.28E–02 1.12E–02 1.03E–02 9.91E–03 1.08E–02 1.06E–02
   Thymus 5.48E–03 4.91E–03 5.73E–03 3.56E–03 3.10E–03 4.31E–03 4.48E–03 4.02E–03 4.45E–03 4.39E–03
   Thyroid 8.34E–03 8.07E–03 1.12E–02 6.05E–03 6.93E–03 6.27E–03 7.57E–03 7.38E–03 7.72E–03 7.47E–03
   Urinary bladder 1.80E–01 1.78E–01 1.22E–01 1.51E–01 4.50E–01 2.67E–01 1.36E–01 3.36E–01 2.27E–01 1.79E–01
   Remainder 7.97E–03 6.80E–03 8.33E–03 5.64E–03 6.28E–03 6.80E–03 6.35E–03 6.38E–03 6.82E–03 6.59E–03
   Effective dose (mSv/MBq) 2.05E–02 1.71E–02 1.75E–02 1.60E–02 3.21E–02 2.25E–02 1.52E–02 2.49E–02 2.07E–02 1.90E–02